FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit
(NASDAQ:FGEN), SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the Oppenheimer Movers in Rare Disease Summit being held on December 11, 2025, in New York, NY. Thane Wettig, Chief Executive Officer of FibroGen, will participate in a panel titled Elevator […]